MedPath
HSA Approval

Apo-Fluconazole 150mg Capsule

SIN13329P

Apo-Fluconazole 150mg Capsule

Apo-Fluconazole 150mg Capsule

August 3, 2007

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J02AC01

fluconazole

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc

Active Ingredients

Fluconazole

150 mg

Fluconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Apo-Fluconazole 150mg Capsule - HSA Approval | MedPath